Back to Rankings

EDIT

Editas MedicineB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-06-02
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
EDIT vs peer average
70/100
EDIT vs. peer average (B vs. C)
Grade spread
A 3 · C 2 · D 3 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

CRDF is the first available peer comparator.

Another development-stage biotech with similar market-cap risk profile; useful as a loose comp for binary milestone reactions and cash-runway discounting.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerCRDFCardiff Oncology
EDIT
Editas Medicine
CRDF
Cardiff Oncology
Grade
B
A
Momentum
82
91
Value
41
41
Sentiment
61
92
Setup Bias
Net Neutral
-
Market Cap
-
-
Posture
Constructive
Constructive

Grade position vs CRDF

EDIT / CRDF
Grade Position
Above peers
EDIT vs. peer average (B vs. C)
70/100
Momentum
82
CRDF
Value
41
EDIT
Sentiment
61
CRDF

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs EDIT
1
CRDF
CRDF
A
100/100
-1
2
TNXP
TNXP
F
20/100
+3
3
CCCC
CCCC
C
60/100
+1
4
FDMT
4D Molecular Therapeutics Inc Common
F
20/100
+3
5
ASMB
Assembly Biosciences Inc Common
D
40/100
+2
CRDF is the first peer returned for this comparison set.